-
In an ideal world, researchers working with mentally ill subjects would be able to present information about their studies in such clear, comprehensive, and organized ways that IRBs could be assured that participants know exactly what to expect.
-
In the summer of 1971, Philip Zimbardo, PhD, was lead investigator on The Stanford Prison Experiment, a study designed to measure the psychological effects that imprisonment and authority would have on participants.
-
-
In the Pipeline
-
Almotriptan malate (Axert) a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, otherwise known as a triptan, was approved by the U.S. Food and Drug Administration (FDA) in May 2001.
-
In other legislation favorable to pharmacists, the Senate Committee on Health, Education, Labor, and Pensions recently passed a bipartisan bill that would provide two student loan repayment programs for certain pharmacists. The bill now moves on to the Senate floor for consideration.
-
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
-
Organizations unveil patient safety road map; PA state legislature puts patient safety in spotlight